Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LF111 drospirenone safety study in adolescent females
NL-OMON40539Phase 3Withdrawn
- Sponsor
- Laboratorios Leon Farma
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of drospirenone in contraception, sponsored by Laboratorios Leon Farma. Planned start Feb 2014; status: withdrawn.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON40539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40539.